Last $0.02 USD
Change Today +0.0132 / 150.00%
Volume 10.0K
VIAP On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jay G. Wohlgemuth M.D.

Senior Vice President of Medical, Science and Innovation, Quest Diagnostics Inc.
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 3 different industries.

See Board Relationships
----

Background*

Dr. Jay G. Wohlgemuth, M.D. serves as Senior Vice President of Medical, Science and Innovation at Quest Diagnostics Inc. Dr. Wohlgemuth served as Senior Vice President of Science and Innovation at Quest Diagnostics Inc. Dr. Wohlgemuth served as Vice President of Research and Development of VIA Pharmaceuticals, Inc. since May 2006. Dr. Wohlgemuth co-founded XDx, Inc., in 2000, where his responsibilities included clinical programs, new product development, R&D and intellectual ...

Read Full Background

Corporate Headquarters*

750 Battery Street
San Francisco, California 94111

United States

Phone: 415-283-2200
Fax: 415-283-2201

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
Harvard College
MD
Stanford University School of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VIAP:US $0.02 USD +0.0132

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Peter D. Meldrum Ph.D.Chief Executive Officer, President and Director
Myriad Genetics Inc.
$956.9K
Peer M. Schatz Chairman of Management Board, Chief Executive Officer and Managing Director
Qiagen NV
$1.5M
Stephen P. MacMillan Chief Executive Officer, President and Director
Hologic Inc.
--
Joseph L. Herring Chairman and Chief Executive Officer
Covance Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.